A Phase 1/2 interventional study of low dose naltrexone in Pervasive Developmental Disorder, sponsored by Hadassah Medical Organization. Status unknown at 1 site in Israel. Open to participants aged 3 Years to 6 Years. Per ClinicalTrials.gov, last updated 2006-05-03.
Sponsored by Hadassah Medical Organization · Phase 1/2, Interventional, and Treatment
This study will examine the effects of low-dose naltrexone (LDN) on children with autistic spectrum disorders. The investigators hope to show a positive effect on social functioning and language.
Fifty children aged three to six years will be recruited for the study. They will be randomly assigned to receive either LDN or placebo for two months after which the treatment groups will be switched over. Assessments of functioning will be obtained from a video-taped play session, and by parent and teacher questionnaires at baseline, after two months and after four months.
285 studies on the registry are indexed under Developmental Disabilities; 64 are open to participants now.
This study's planned enrollment of 50 is below the median of 60 across 199 interventional studies indexed under Developmental Disabilities.
Browse Developmental Disabilities studies →Hadassah Medical Organization is the lead sponsor of 659 studies on the registry; 54 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Inclusion Criteria:
play observation
Autism Behavior Checklist (ABC) questionnaire
This study is status unknown, as verified in Apr 2006. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Hadassah Medical Organization